JAMA Oncology : Survival and Adjuvant Chemotherapy in Early-Stage NSCLC With vs Without Clinicopathologic Features

Interview with Daniel J Boffa, MD, author of Association of Survival With Adjuvant Chemotherapy Among Patients With Early-Stage Non–Small Cell Lung Cancer With vs Without High-Risk Clinicopathologic Features

Source: JAMA Specialty Journals Author Interviews - September 17, 2020 Category: General Medicine Authors: The JAMA Network Source Type: podcasts